Corrigendum to “Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancer” [Redox Biol. 88 (2025) 103895]

Journal of Autoimmunity · Elsevier

Аннотация

Publication date: November 2026 Source: Redox Biology, Volume 97 Author(s): Gayle S. Jameson, S. Danielle LeGrand, Michael S. Gordon, Denise J. Roe, Betsy C. Wertheim, Kellen Olszewski, Josh Rabinowitz, Ron Evans, Michael Downes, Morgan Truitt, Ron Korn, Haiyong Han, Richard M. Miller, Michael T. Barrett, David Propper, Daniel D. Von Hoff, Erkut Borazanci

Читать у издателя →

Похожие статьи